Selank
Selank is a synthetic seven-amino-acid peptide derived from the immune protein tuftsin, developed in Russia. Research shows it has both immune-supporting and anti-anxiety properties without causing sedation or dependence.
Verified sources for Selank
These vendors are vetted by PeptideWiki for purity testing and COA transparency.
Overview of Selank
Modulates GABA-A receptors and enhances enkephalin activity to reduce anxiety, while regulating cytokines for immunomodulatory effects.
Enhances GABAergic neurotransmission, producing anxiolytic effects comparable to benzodiazepines without sedation or dependence.
Inhibits enkephalinase enzymes, increasing endogenous enkephalin levels and modulating opioid system for stress relief.
No tolerance, dependence, or cognitive impairment unlike benzodiazepines, with a favorable safety profile.
Modulates pro- and anti-inflammatory cytokines (suppresses IL-6, TNF-α), providing immunomodulatory effects alongside anxiolytic properties.
Affects expression of genes involved in GABAergic neurotransmission, which may induce interferon secretion for antiviral activity
Read Full Selank Dosage Guide
Research-backed dosing protocols, timing, and administration details
Browse more in this category
Cognition, Mood & Neuroprotection
Selank vs Semax: The Russian Nootropic Peptide Comeback
Selank and Semax are Russia's two best-known nootropic peptides. One is heading back to FDA review; the other isn't. Compare mechanisms and research.
Peptide Therapy for Sleep Optimization: The Quiet Trend Reshaping Recovery in 2026
Peptide therapy is quietly becoming the most promising frontier in sleep science. From DSIP to growth hormone secretagogues, here's how peptides are being studied for deep sleep and recovery.
RFK Jr. Says 14 Peptides Are Coming Back: Ban Reversal
HHS Secretary RFK Jr. told Joe Rogan that ~14 peptides banned by the FDA in 2023 will return to Category 1, restoring legal compounding access.